Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AH.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.280EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.597EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.45EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.72EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.43EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.85EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.66 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.72 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.133 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.5.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.43.7 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.33.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.493EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.351.2 (Beta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.640.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.352EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.251EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCJEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FT.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HH.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KN.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.43.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.332EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JB.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.86.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JW.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.6.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.39EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.141EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.591EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.468EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.131 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.586EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.366EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.380EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.148EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.382EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.356EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.376EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.607EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.163EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.337EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.158EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.602EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.289EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used